Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more

Start Your Claim

Claiming and managing your profile is free. Enter any email you have access to. In the next step, we'll give you a small snippet to place on the organization's website to verify ownership.

Email address

We'll use this to process your claim and send important profile updates.

Need help? Contact us

: Verified by RoundPaper

FY 2024

Verified NonprofitLast Filed 2024EIN 27-3217520

The Hpv and Anal Cancer Foundation

NEW YORK, NYNTEE: H30Founded 2010Website

mission statement

To empower anal cancer patients and accelerate prevention and research methods that eliminate anal cancer and the virus that causes the majority of cases, human papillomavirus (HPV).

Share this profile

Total Revenue

$310K

FY 2024

Program Spending

80.1%

of total expenses

Known Funders

2019–2024 filings

Key Metrics (FY 2024)

The Numbers

$1.0M

Total Assets

$1.0M net

36.87 mo

Operating Reserves

FY 2024

Active Programs

FY 2024

Total Employees

FY 2024

Funding Track Record

Backed by 15 Institutional Funders

$484K raised across 28 grants (2019–2024 filings)

Funder Geography

Funders across 8 states (2019–2024 filings)

Institutional Funding by Year

PaidCommittedBoth

Funder	Location	Total Awarded
The Goldman Sachs Charitable Gift Fund	NEW YORK, NY	$297,000
Paypal Charitable Giving Fund	WASHINGTON, DC	$60,501
The Farrah Fawcett Foundation	BEVERLY HILLS, CA	$36,000
National Philanthropic Trust	JENKINTOWN, PA	$16,000
Fidelity Investments Charitable Gift Fund	BOSTON, MA	$13,310
Belvedere Charitable Foundation	NEW YORK, NY	$12,469
American Online Giving Foundation Inc	NEWARK, DE	$11,200
Donor Advised Charitable Giving Inc	SAN FRANCISCO, CA	$10,000
Vanguard Charitable Endowment Program	SOUTHEASTERN, PA	$10,000
Grey Rocks Foundation Inc	BOSTON, MA	$10,000

Total tracked: $483,891 across 28 grants (2019–2024 filings)

Totals reflect grants as reported on funder tax returns. Timing may not match recipient revenue: funder and recipient fiscal years often differ, and grants paid by a funder in one year may be recognized by the recipient in a different year.

Programs (FY 2024)

What They Do

$158K in expenses

Education: hpvacf educates the general public and medical community about the human papillomavirus (HPV) and the cancers it causes. Hpvacf increases access to, and awareness of, preventing HPV-related cancers through cancer preventing screening and vaccination. The organization raises awareness and disseminates information through a variety of methods, including public platforms, forums, athletic events and partnerships.

$96K in expenses

Patient: hpvacf provides robust resources, information and community initiatives to anal cancer patients and caregivers. Hpvacf educational and community forums bring patients, caregivers and providers together to empower each other and become informed. To address isolation in the community, hpvacf established the first formal anal cancer peer-peer support program that matches thrivers and caregivers with peers who have experienced anal cancer.

$11K in expenses

Research: hpvacf provides funding to accelerate new, effective drugs to treat HPV-related cancers, including anal cancer, and to build the scientific/medical infrastructure to create better treatment and prevention methods. This program has created the first anal neoplasia medical society, and funded ground-breaking research to find a cure for anal cancer and HPV-related cancers, especially in the field of immunotherapy.

Financial History